News

Two of these medicines are for the treatment of psoriasis and a third has been accepted for psoriatic arthritis. The other new medicines accepted are the latest of

The partnership demonstrates Tillotts’ commitment to developing new treatments to improve care for patients with IBD and, upon successful development, will add to a strong track record in

The alliance will try to identify, assess and work on fertility-related laboratory processes, co-ordinate to improve consistency in ART worldwide and is likely to be a solution for

eHealthStore was created through CPM’s strategic alliance with Retailigence, a leading platform connecting marketers with a nationwide shopper audience on the path-to-purchase. Through this new development, CPM now

IMO-2125 is a TLR9 agonist that was assessed subcutaneously in around 80 human subjects. It was well tolerated and demonstrated to induce immune responses. Idera Pharmaceuticals CEO Vincent

The fruit punch tablets are the latest product in the line of the company’s performance energy offerings, and currently available at several sports specialty retail stores across the

The acquisition will create a broad portfolio of commercial products and also position Pozen to expand its foreign presence through potential international sales and licensing, manufacturing and product

TX-004HR is an investigational bio-identical estradiol softgel capsule that can be administered vaginally without the need for an applicator. The pivotal safety and efficacy Rejoice trial is a

The SEC alleges that Michael J. Fefferman learned material nonpublic information as senior director of information technology at Ardea Biosciences Inc. He tipped his brother-in-law Chad E. Wiegand